Skip to content
Screener

Liquidia Corporation LQDA Business Segments — Non Program Expenses

Similar metrics at other companies

Ocular Therapeutix logo
OCULSingle Reportable — Research And Development Expense Retina Program One
$42.46M+72.3%
Alumis Inc. logo
ALMSSingle Reportable — Operating Expenses
$100.15M-15.8%
Immunome logo
IMNMSingle Reportable — Operating Expenses
-$59.33M-24.7%
Theravance Biopharma logo
TBPHSingle Reportable — Operating Expenses
$27.18M-8.9%
Dogwood Therapeutics logo
DWTXSingle Reportable — Operating Expenses
$5.08M+14.6%
SES AI logo
SESSingle Reportable — Operating Expenses
$19.08M-31.4%

Other financials

Income statement

See full
Revenue$132.9M+4,158%
Gross profit$1.6M+6.5%
Operating income$61.5M+274%
Net income$52.9M+238%
EPS (diluted)$0.52+216%

Balance sheet

See full
Cash & equivalents$222.8M+31.2%
Total debt$7.0M+1.5%
Total equity$108.6M+118%
Total assets$401.5M+76.6%

Cash flow

See full
Operating cash flow$53.0M+273%
CapEx$2.8M+758%
Free cash flow$50.2M+262%

Valuation

See full
Market cap$7.93B+356%
Enterprise value$7.71B+391%
P/S27.5×-62.3×

Profitability

See full
Gross margin58.1%-18.7pp
Operating margin-155%-68.1pp
Net margin-176.2%-76.4pp
FCF margin-150.7%-64.4pp

Returns & leverage

See full
Return on equity-181%+57.4pp
Debt / equity0.1×-0.1×
Current ratio2.2×-0.7×

Where this comes from

Reported directly by Liquidia Corporation in its filing.

Tagged under the XBRL concept lqda:NonProgramExpenses.

The source filing: Liquidia Corporation’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 7:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-058252
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
L6065,8223,268
Generic Treprostinil(49)151
Total program expenses21,66113,177
Non-program expenses (2)6,1973,770
Personnel, including stock-based compensation31,65120,081
Income (loss) from operations61,504(35,425)
Other income (expense), net(4,722)(2,942)
Income (loss) before income taxes$56,782$(38,367)

Item 1. Condensed Financial Statements (unaudited)

FAQ

What is Liquidia Corporation's business segments — non program expenses?
Liquidia Corporation (LQDA) reported business segments — non program expenses of $6.2M in Q1 2026.
How has Liquidia Corporation's business segments — non program expenses changed year-over-year?
Liquidia Corporation's business segments — non program expenses increased by 64.4% year-over-year, from $3.77M to $6.2M.
What does business segments — non program expenses mean?
This metric includes general administrative, overhead, and other operational costs that are not directly tied to specific research or development programs. It provides insight into the company's fixed cost structure and the efficiency of its corporate support functions. Managing these costs is essential for maintaining operational leverage as the company scales.

Ask your AI about Liquidia Corporation's business segments — non program expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude